None listed
Conditions
Brief summary
On March 11, 2020, WHO declared that the COVID-19 epidemic had become a pandemic. Health authorities around the word are taking measures to increase conventional hospitalization and intensive care capacity. So, the way surgery is performed have changed. Emergency surgery remains a priority, and functional surgery has to be postponed. The main question concerns oncological surgery, operate or postpone? There is probably a risk induced by the pandemic COVID 19 which must be balanced against the oncological risk linked to delay in surgery. A Chinese report described that cancer patients are more likely to develop infection by the virus due to their immunosuppression secondary to cancer, chemotherapy and surgery. This article also highlights that these patients are at higher risk of developing severe episodes (39% vs 8%). Patients who underwent surgery or received chemotherapy in the month before the virus appeared had a greater risk (75%) of developing a severe episode than those who did not undergo surgery or did not receive chemotherapy (43%). The objective of our report is to share our experience of performing scheduled and urgent surgery in COVID-19 pandemic. We report the perioperative characteristics and outcome of patients in whom surgery was undertaken.
Interventions
incidence of Sars-COV-2 infection in patients undergoing surgery from Feburary 2020 to April 2020
No involvment for the patients, and the medical charts will be review to gather informations needed.
For each participant medical chart will be check 2 weeks after surgery or at the date of hospital discharge if their hospital stay is longer than two weeks
Sponsors
Anesthesiology Intensive Care and peri operative medicine department, Tenon hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Adult (18+ years old) patients undergoing surgery
Exclusion criteria
Pre operative confirmed Sars-COV-2 infection
Outcome results
None listed